[Activity of sebaceous glands from the aspect of endocrine processes].
D000172:Acromegaly / Q000378:metabolism; D000312:Adrenal Hyperplasia, Congenital / Q000378:metabolism; D045930:Anabolic Agents / Q000009:adverse effects / Q000494:pharmacology; D000726:Androgen Antagonists; D000818:Animals; D003480:Cushing Syndrome / Q000378:metabolism; D003534:Cyproterone / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D005849:Gerbillinae; D006801:Humans; D007018:Hypopituitarism / Q000378:metabolism; D007818:Laryngeal Diseases / Q000139:chemically induced; D008297:Male; D011085:Polycystic Ovary Syndrome / Q000378:metabolism; D011245:Pregnadienes / Q000494:pharmacology*; D012627:Sebaceous Glands / Q000187:drug effects* / Q000502:physiology; D012867:Skin / Q000187:drug effects; D013739:Testosterone / Q000494:pharmacology*
D045930:Anabolic Agents; D000726:Androgen Antagonists; D004967:Estrogens; D011245:Pregnadienes; D013739:Testosterone; D003534:Cyproterone
Talgrüsenaktivität im Spiegel endokriner Vorgänge.